Bio-Techne Corp. Stock
Bio-Techne Corp. Stock
Heavy losses for Bio-Techne Corp. today as the stock fell by -€1.640 (-3.780%).
With 22 Buy predictions and not a single Sell prediction Bio-Techne Corp. is an absolute favorite of our community.
With a target price of 60 € there is a positive potential of 46.2% for Bio-Techne Corp. compared to the current price of 41.04 €.
So far the community has only identified positive things for Bio-Techne Corp. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Bio-Techne Corp. in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
B****
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bio-Techne Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bio-Techne Corp. | -3.780% | -12.940% | -11.628% | -7.568% | -17.920% | -44.541% | - |
| Bio-Rad Labs Inc. A | -2.100% | -9.472% | -10.150% | 0.465% | -16.247% | -35.484% | -56.800% |
| CONMED Corp. | -3.110% | 0.645% | -1.266% | -38.824% | -10.857% | -71.892% | -73.559% |
| Glaukos Corp | -1.750% | -7.438% | 9.804% | 41.772% | 16.062% | 115.385% | 64.706% |
Comments
Bio-Techne (TECH) had its price target lowered by Citigroup Inc. from $80.00 to $70.00. They now have a "buy" rating on the stock.
Show more
Ratings data for TECH provided by MarketBeat
Bio-Techne (TECH) had its price target lowered by Wells Fargo & Company from $76.00 to $62.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for TECH provided by MarketBeat
Bio-Techne (TECH) had its "buy" rating reaffirmed by TD Cowen.
Show more
Ratings data for TECH provided by MarketBeat